| Adam M Starr, MD | |
|
18 Medical Park Dr., Asheville, NC 28803 | |
| (828) 253-7521 | |
| (828) 251-5992 |
| Full Name | Adam M Starr |
|---|---|
| Gender | Male |
| Speciality | Orthopedic Surgery |
| Experience | 24 Years |
| Location | 18 Medical Park Dr., Asheville, North Carolina |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1215101373 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| Highlands Cashiers Hospital | Highlands, NC | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Restor Metabolix Of Asheville, Llc | 6800284548 | 3 |
| Carolina Hand And Sports Medicine, P.a. | 7719970383 | 8 |
News Archive
Researchers at Karolinska Institutet collaborating in the large-scale Karolinska Schizophrenia Project are taking an integrative approach to unravel the disease mechanisms of schizophrenia.
A new study has found that some kinds of infection data may not be comparable across hospitals, and may not be suitable for use as a performance measure.
With major changes to Medicare likely on hold for the time being, advocates say the GOP has Medicaid "in its sights" as a more realistic place to make health care cuts.
Quintiles today announced a strategic alliance with Movetis NV for commercialization of its new product, Resolor (prucalopride), in the U.K. and Germany. Under the alliance, Quintiles will execute a comprehensive commercial sales effort for the product launch and provide additional services in consulting, market access, market intelligence and analytics, regulatory and post-marketing pharmacovigilance.
› Verified 7 days ago
| Entity Name | Carolina Hand And Sports Medicine, P.a. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1689778300 PECOS PAC ID: 7719970383 Enrollment ID: O20040407001526 |
News Archive
Researchers at Karolinska Institutet collaborating in the large-scale Karolinska Schizophrenia Project are taking an integrative approach to unravel the disease mechanisms of schizophrenia.
A new study has found that some kinds of infection data may not be comparable across hospitals, and may not be suitable for use as a performance measure.
With major changes to Medicare likely on hold for the time being, advocates say the GOP has Medicaid "in its sights" as a more realistic place to make health care cuts.
Quintiles today announced a strategic alliance with Movetis NV for commercialization of its new product, Resolor (prucalopride), in the U.K. and Germany. Under the alliance, Quintiles will execute a comprehensive commercial sales effort for the product launch and provide additional services in consulting, market access, market intelligence and analytics, regulatory and post-marketing pharmacovigilance.
› Verified 7 days ago
| Entity Name | Angel Medical Center Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1497753651 PECOS PAC ID: 9638253297 Enrollment ID: O20090312000353 |
News Archive
Researchers at Karolinska Institutet collaborating in the large-scale Karolinska Schizophrenia Project are taking an integrative approach to unravel the disease mechanisms of schizophrenia.
A new study has found that some kinds of infection data may not be comparable across hospitals, and may not be suitable for use as a performance measure.
With major changes to Medicare likely on hold for the time being, advocates say the GOP has Medicaid "in its sights" as a more realistic place to make health care cuts.
Quintiles today announced a strategic alliance with Movetis NV for commercialization of its new product, Resolor (prucalopride), in the U.K. and Germany. Under the alliance, Quintiles will execute a comprehensive commercial sales effort for the product launch and provide additional services in consulting, market access, market intelligence and analytics, regulatory and post-marketing pharmacovigilance.
› Verified 7 days ago
| Entity Name | Mission Medical Associates Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1114150190 PECOS PAC ID: 0749326106 Enrollment ID: O20100313000054 |
News Archive
Researchers at Karolinska Institutet collaborating in the large-scale Karolinska Schizophrenia Project are taking an integrative approach to unravel the disease mechanisms of schizophrenia.
A new study has found that some kinds of infection data may not be comparable across hospitals, and may not be suitable for use as a performance measure.
With major changes to Medicare likely on hold for the time being, advocates say the GOP has Medicaid "in its sights" as a more realistic place to make health care cuts.
Quintiles today announced a strategic alliance with Movetis NV for commercialization of its new product, Resolor (prucalopride), in the U.K. and Germany. Under the alliance, Quintiles will execute a comprehensive commercial sales effort for the product launch and provide additional services in consulting, market access, market intelligence and analytics, regulatory and post-marketing pharmacovigilance.
› Verified 7 days ago
| Entity Name | Mission Hospitals Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1548532021 PECOS PAC ID: 0648189969 Enrollment ID: O20120316000506 |
News Archive
Researchers at Karolinska Institutet collaborating in the large-scale Karolinska Schizophrenia Project are taking an integrative approach to unravel the disease mechanisms of schizophrenia.
A new study has found that some kinds of infection data may not be comparable across hospitals, and may not be suitable for use as a performance measure.
With major changes to Medicare likely on hold for the time being, advocates say the GOP has Medicaid "in its sights" as a more realistic place to make health care cuts.
Quintiles today announced a strategic alliance with Movetis NV for commercialization of its new product, Resolor (prucalopride), in the U.K. and Germany. Under the alliance, Quintiles will execute a comprehensive commercial sales effort for the product launch and provide additional services in consulting, market access, market intelligence and analytics, regulatory and post-marketing pharmacovigilance.
› Verified 7 days ago
| Entity Name | Restor Metabolix Of Asheville, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1063181931 PECOS PAC ID: 6800284548 Enrollment ID: O20211028001928 |
News Archive
Researchers at Karolinska Institutet collaborating in the large-scale Karolinska Schizophrenia Project are taking an integrative approach to unravel the disease mechanisms of schizophrenia.
A new study has found that some kinds of infection data may not be comparable across hospitals, and may not be suitable for use as a performance measure.
With major changes to Medicare likely on hold for the time being, advocates say the GOP has Medicaid "in its sights" as a more realistic place to make health care cuts.
Quintiles today announced a strategic alliance with Movetis NV for commercialization of its new product, Resolor (prucalopride), in the U.K. and Germany. Under the alliance, Quintiles will execute a comprehensive commercial sales effort for the product launch and provide additional services in consulting, market access, market intelligence and analytics, regulatory and post-marketing pharmacovigilance.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Adam M Starr, MD 18 Medical Park Dr., Asheville, NC 28803 Ph: (828) 253-7521 | Adam M Starr, MD 18 Medical Park Dr., Asheville, NC 28803 Ph: (828) 253-7521 |
News Archive
Researchers at Karolinska Institutet collaborating in the large-scale Karolinska Schizophrenia Project are taking an integrative approach to unravel the disease mechanisms of schizophrenia.
A new study has found that some kinds of infection data may not be comparable across hospitals, and may not be suitable for use as a performance measure.
With major changes to Medicare likely on hold for the time being, advocates say the GOP has Medicaid "in its sights" as a more realistic place to make health care cuts.
Quintiles today announced a strategic alliance with Movetis NV for commercialization of its new product, Resolor (prucalopride), in the U.K. and Germany. Under the alliance, Quintiles will execute a comprehensive commercial sales effort for the product launch and provide additional services in consulting, market access, market intelligence and analytics, regulatory and post-marketing pharmacovigilance.
› Verified 7 days ago
Peter G Mangone, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 60 Livingston St, Suite 100, Asheville, NC 28801 Phone: 828-258-8800 Fax: 828-281-7178 | |
Dr. Keith M Maxwell, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 21 Turtle Creek Dr, Asheville, NC 28803 Phone: 828-274-4555 Fax: 828-274-3615 | |
Dr. Pamela Gutbier Meliski, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 75b Livingston St, Asheville, NC 28801 Phone: 828-258-8800 | |
Dr. Wallace Taylor Harris, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 75b Livingston St, Asheville, NC 28801 Phone: 828-258-8800 | |
Michael J Goebel, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 75b Livingston St, Asheville, NC 28801 Phone: 828-258-8800 Fax: 828-281-7178 | |
Charles M. Lecroy, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 509 Biltmore Ave, Asheville, NC 28801 Phone: 828-213-1995 | |
Andrew V Prizigley, PA-C Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 7 Vanderbilt Park Dr, Asheville, NC 28803 Phone: 828-255-7776 |